Investor Schindel Yair Chaim
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Schindel Yair Chaim . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-01-08 13G/A SEER / Seer, Inc. 4,923,196 4,923,196
2024-11-04 13G/A AKYA / Akoya Biosciences, Inc. 3,077,195 4,878,459
2024-11-04 13G/A SERA / Sera Prognostics, Inc. 2,978,511 1,911,332
2024-02-12 13G/A ADXS / Ayala Pharmaceuticals, Inc. 560,602 560,602
2024-01-03 13G/A SEER / Seer, Inc. 4,923,196 4,923,196
2024-01-03 13G/A SERA / Sera Prognostics, Inc. 1,918,511 2,978,511
2024-01-03 13G/A AKYA / Akoya Biosciences, Inc. 2,918,439 3,077,195
2023-10-23 13G/A ADXS / Ayala Pharmaceuticals, Inc. 560,602 560,602
2023-06-13 13G AKYA / Akoya Biosciences, Inc. 2,918,439
2023-05-18 13D/A SOPH / SOPHiA GENETICS SA 3,210,867 4,933,205
2023-01-30 13G ADXS / Ayala Pharmaceuticals, Inc. 560,602
2023-01-23 13G/A AYLA / Ayala Pharmaceuticals Inc 2,991,473 0
2023-01-10 13D/A VIRX / Viracta Therapeutics, Inc. 7,392,237 7,392,237
2023-01-10 13D/A VIRX / Viracta Therapeutics, Inc. 7,392,237 7,392,237
2023-01-10 13D SOPH / SOPHiA GENETICS SA 3,210,867
2023-01-09 13G/A SEER / Seer, Inc. 4,923,196 4,923,196
2023-01-09 13G/A SERA / Sera Prognostics, Inc. 1,918,511 1,918,511
2023-01-09 13G/A AYLA / Ayala Pharmaceuticals Inc 2,991,473 2,991,473
2022-01-24 13G SERA / Sera Prognostics, Inc. 1,918,511
2022-01-24 13G/A AYLA / Ayala Pharmaceuticals Inc 2,991,473 2,991,473
2022-01-24 13G/A SEER / Seer, Inc. 5,923,196 4,923,196
2021-03-02 13D VIRX / Viracta Therapeutics, Inc. 7,392,237
2021-02-18 13D/A ACET / Adicet Bio, Inc. 1,104,460 1,214,907
2021-02-08 13G SEER / Seer, Inc. 5,923,196
2021-02-08 13G AYLA / Ayala Pharmaceuticals Inc 2,991,473
2020-12-03 13D/A ACET / Adicet Bio, Inc. 1,134,460 1,104,460
2020-09-24 13D ACET / Adicet Bio, Inc. 1,134,460